Fewer than 0.5% of SARS-CoV-2 sequences available in GISAID are from Africa, despite Africa representing 14% of the world’s population. While some African institutions have access to genomic sequencing technology, this is not widespread due to high upfront costs, a limited well-trained workforce, and limited infrastructure for data systems. By creating a collaborative program for genomic sequencing of SARS-CoV-2 in Nigeria, Kenya, and South Africa that supports other African countries, we will spearhead the Africa genomics surveillance revolution. Genomics surveillance aims... read more
